Company: RENEF
Filing Date: 2025-10-08
Form Type: PRE 14A
Source: 0001104659-25-097940
Chunk: 18

Company: Cartesian Growth Corp II
Filing Date: 2025-10-08
Form: PRE 14A
Chunk 18
---
 may (i) purchase public shares from institutional and other investors (including those who vote, or indicate
an intention to vote, against any of the proposals presented at the Extraordinary General Meeting, or elect to redeem, or indicate an
intention to redeem, public shares), (ii) enter into transactions with such investors and others to provide them with incentives to not
redeem their public shares, or (iii) execute agreements to purchase such public shares from such investors or enter into non-redemption
agreements in the future. In the event that the Sponsor, the Company’s directors, officers, advisors or any of their respective
affiliates purchase public shares in situations in which the tender offer rules restrictions on purchases would apply, they (a) would
purchase the public shares at a price no higher than the price offered through the Company’s redemption process (i.e., approximately
$[ ] per share, based on the amounts held in the Trust Account as of October [
], 2025); (b) would represent in writing that such public shares will not be voted in favor of approving the Extension; and (c) would
waive in writing any redemption rights with respect to the public shares so purchased.

<div align='center'>4</div>

To the extent any such purchases
by the Sponsor, the Company’s directors, officers, advisors or any of their respective affiliates are made in situations in which
the tender offer rules restrictions on purchases apply, the Company will disclose in a Current Report on Form 8-K prior to the Extraordinary
General Meeting the following: (i) the number of public shares purchased outside of the redemption offer, along with the purchase price(s)
for such public shares; (ii) the purpose of any such purchases; (iii) the impact, if any, of the purchases on the likelihood that the
Extension will be approved; (iv) the identities of the securityholders who sold to the Sponsor, the Company’s directors, officers,
advisors or any of their respective affiliates (if not purchased on the open market) or the nature of the securityholders (e.g., 5% security
holders) who sold such public shares; and (v) the number of Ordinary Shares for which the Company has received redemption requests pursuant
to its redemption offer.

The purpose of such share
purchases and other transactions would be to limit the number of public shares electing to redeem.

If such transactions are
effected, the consequence could be to cause the Extension to